|
|
|
Insider
Information: |
Bilinsky Igor |
Relationship: |
Chief Operating Officer |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
248,220 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$634,411 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
248,220 |
|
|
Total
Value |
$634,411 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Sr VP, Corporate Devel... |
2015-07-13 |
193,798 |
|
0 |
Premium* |
|
Iovance Biotherapeutics Inc |
IOVA |
Chief Operating Officer |
2024-09-03 |
54,422 |
2022-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2022-06-14 |
4 |
D |
$7.73 |
$72,245 |
D/D |
(9,346) |
9,504 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-01-03 |
4 |
D |
$6.11 |
$64,479 |
D/D |
(10,553) |
17,801 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,850 |
18,850 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-01-17 |
4 |
D |
$6.43 |
$30,035 |
D/D |
(4,671) |
24,378 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-04-14 |
4 |
D |
$5.64 |
$7,868 |
D/D |
(1,395) |
25,795 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
27,190 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-07-14 |
4 |
D |
$7.76 |
$10,825 |
D/D |
(1,395) |
27,213 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,850 |
28,354 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-07-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
28,608 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-10-16 |
4 |
D |
$3.57 |
$4,980 |
D/D |
(1,395) |
28,631 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,248 |
29,049 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-01-16 |
4 |
D |
$8.37 |
$13,199 |
D/D |
(1,577) |
29,867 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2023-10-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
30,026 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
31,444 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-03-04 |
4 |
D |
$16.96 |
$123,588 |
D/D |
(7,287) |
36,641 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-04-15 |
4 |
D |
$11.89 |
$16,967 |
D/D |
(1,427) |
38,026 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
39,453 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-06-03 |
4 |
D |
$8.37 |
$14,932 |
D/D |
(1,784) |
39,758 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-07-15 |
4 |
D |
$8.68 |
$12,395 |
D/D |
(1,428) |
41,143 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,516 |
41,542 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
42,571 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,061 |
43,928 |
0 |
- |
|
IOVA |
Iovance Biotherapeutics I... |
Chief Operating Officer |
|
2024-09-03 |
4 |
D |
$10.85 |
$148,374 |
D/D |
(13,675) |
54,422 |
0 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Senior VP, Corporate Devt |
|
2014-01-07 |
4 |
D |
$1.31 |
$71 |
D/D |
(54) |
55,692 |
0 |
- |
|
FRTX |
Fresh Tracks Therapeutics... |
Senior VP, Corporate DevtOffic |
|
2013-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,746 |
|
- |
|
38 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|